SEC 13F Intelligence

Norges Bank / ELV

Norges Bank’s Elevance Health Inc Formerly Position

Does Norges Bank own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 3.02M shares worth $1.1B in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$1.1B
Q4 2025
Shares
3.02M
% of Portfolio
+0.11%
Quarters Held
31
position exited

Position History ELV

Reported value by quarter
Q1 ’18: $530MQ1 ’18Q2 ’18: $588MQ3 ’18: $676MQ4 ’18: $667MQ1 ’19: $729MQ1 ’19Q2 ’19: $724MQ3 ’19: $616MQ4 ’19: $775MQ1 ’20: $568MQ1 ’20Q2 ’20: $714MQ3 ’20: $729MQ4 ’20: $867MQ1 ’21: $970MQ1 ’21Q2 ’21: $980MQ3 ’21: $923MQ4 ’21: $1.1BQ1 ’22: $1.1BQ1 ’22Q2 ’22: $1.1BQ3 ’22: $1.0BQ4 ’22: $1.3BQ1 ’23: $1.1BQ1 ’23Q2 ’23: $1.1BQ3 ’23: $1.1BQ4 ’23: $1.3BQ1 ’24: $1.4BQ1 ’24Q2 ’24: $1.7BQ3 ’24: $1.5BQ4 ’24: $1.1BQ1 ’25: $1.3BQ1 ’25Q2 ’25: $1.1BQ4 ’25: $1.1Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20253.02M$1.1B+0.11%
Q2 20252.95M$1.1B+0.14%
Q1 20252.99M$1.3B+0.18%
Q4 20243.08M$1.1B+0.15%
Q3 20242.98M$1.5B+0.22%
Q2 20243.05M$1.7B+0.25%
Q1 20242.72M$1.4B+0.22%
Q4 20232.86M$1.3B+0.24%
Q3 20232.59M$1.1B+0.23%
Q2 20232.58M$1.1B+0.23%
Q1 20232.50M$1.1B+0.25%
Q4 20222.44M$1.3B+0.30%
Q3 20222.28M$1.0B+0.28%
Q2 20222.24M$1.1B+0.28%
Q1 20222.31M$1.1B+0.25%
Q4 20212.43M$1.1B+0.23%
Q3 20212.48M$923M+0.20%
Q2 20212.57M$980M+0.21%
Q1 20212.70M$970M+0.22%
Q4 20202.70M$867M+0.20%
Q3 20202.72M$729M+0.19%
Q2 20202.72M$714M+0.21%
Q1 20202.50M$568M+0.20%
Q4 20192.57M$775M+0.22%
Q3 20192.57M$616M+0.19%
Q2 20192.57M$724M+0.22%
Q1 20192.54M$729M+0.24%
Q4 20182.54M$667M+0.25%
Q3 20182.47M$676M+0.22%
Q2 20182.47M$588M+0.20%
Q1 20182.41M$530M+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norges Bank’s full portfolio or all institutional holders of ELV.